Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PfSPZ-DVI Challenge in Healthy Volunteers
NCT04310085Phase 1Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Feb 2020
- Primary completion
- Dec 2020
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PfSPZ Challenge in malaria, sponsored by Medicines for Malaria Venture. Primary endpoints: Incidence and Severity of Observed or Self-reported Adverse Events (AEs) Considered PfSPZ-DVI Challenge Inoculum-related, Change in Malaria Clinical Score From PfSPZ-DVI Challenge Until Parasite Clearance and 7 more. Started Feb 2020; status: completed.
02
Drugs
PfSPZ Challenge
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04310085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04310085.